Insider Trading & Ownership - Prelude Therapeutics Inc (PRLD)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Prelude Therapeutics Inc
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-24
Purchase
2023-05-26
4:20 pm
Prelude Therapeutics IncPRLDVaddi Krishna
CEO
1,900$5.1528$9,7902,715,145
(Indirect
Direct)
View
2023-05-24
Purchase
2023-05-25
4:07 pm
Prelude Therapeutics IncPRLDLim Bryant David
Chief Legal Officer, Corp Sec.
2,400$5.39$12,9362,400
(Direct)
View
2023-05-23
Purchase
2023-05-25
4:05 pm
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
5,000$5.5$27,50042,165
(Direct)
View
2023-05-23
Purchase
2023-05-25
4:03 pm
Prelude Therapeutics IncPRLDVaddi Krishna
CEO
11,856$5.63$66,7492,713,245
(Indirect
Direct)
View
2023-05-22
Purchase
2023-05-24
5:09 pm
Prelude Therapeutics IncPRLDORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
ORBIMED CAPITAL LLC
Director
10% Owner
869,565$5.75$4,999,99910,646,056
(Indirect)
View
2023-05-22
Purchase
2023-05-24
5:07 pm
Prelude Therapeutics IncPRLDBonita David P
Director
10% Owner
869,565$5.75$4,999,99910,646,056
(Indirect)
View
2023-04-06
Sale
2023-04-06
6:19 pm
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
13,280$6.12$81,274136,720
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-04
Tax Withholding
2024-10-07
4:10 pm
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
3,349$2119,591
(Direct)
View
2024-10-04
Exercise
2024-10-07
4:10 pm
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
9,375$0119,591
(Direct)
View
2024-07-04
Tax Withholding
2024-07-08
4:02 pm
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
3,347$3.6122,940
(Direct)
View
2024-07-04
Exercise
2024-07-08
4:02 pm
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
9,375$0122,940
(Direct)
View
2024-06-14
Option Award
2024-06-18
4:26 pm
N/A
2034-06-13
Prelude Therapeutics IncPRLDBAKER BROS. ADVISORS LP
667 L.P.
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Director
10% Owner
47,000$047,000
(Indirect)
View
2024-06-14
Option Award
2024-06-18
4:14 pm
N/A
2034-06-13
Prelude Therapeutics IncPRLDSandor Victor
Director
23,500$023,500
(Direct)
View
2024-06-14
Option Award
2024-06-18
4:13 pm
N/A
2034-06-13
Prelude Therapeutics IncPRLDFRIEDMAN PAUL A
Director
23,500$023,500
(Direct)
View
2024-06-14
Option Award
2024-06-18
4:13 pm
N/A
2034-06-13
Prelude Therapeutics IncPRLDDier Mardi
Director
23,500$023,500
(Direct)
View
2024-06-14
Option Award
2024-06-18
4:12 pm
N/A
2034-06-13
Prelude Therapeutics IncPRLDBonita David P
Director
10% Owner
23,500$023,500
(Direct)
View
2024-06-14
Option Award
2024-06-18
4:11 pm
N/A
2034-06-13
Prelude Therapeutics IncPRLDBabler Martin
Director
23,500$023,500
(Direct)
View
2024-05-14
Option Award
2024-05-16
4:00 pm
N/A
2034-05-13
Prelude Therapeutics IncPRLDLim Bryant David
CLO, Interim CFO, Corp Sec.
25,000$025,000
(Direct)
View
2024-04-04
Exercise
2024-04-08
4:11 pm
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
9,375$0126,287
(Direct)
View
2024-04-04
Tax Withholding
2024-04-08
4:11 pm
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
3,347$4.74126,287
(Direct)
View
2024-03-01
Option Award
2024-03-04
6:07 pm
N/A
2034-02-28
Prelude Therapeutics IncPRLDLim Bryant David
Chief Legal Officer, Corp Sec.
150,000$0150,000
(Direct)
View
2024-03-01
Option Award
2024-03-04
6:07 pm
N/A
2034-02-28
Prelude Therapeutics IncPRLDScherle Peggy
Chief Scientific Officer
150,000$0150,000
(Direct)
View
2024-03-01
Option Award
2024-03-04
6:05 pm
N/A
2034-02-28
Prelude Therapeutics IncPRLDCombs Andrew
Chief Chemistry Officer
150,000$0150,000
(Direct)
View
2024-03-01
Option Award
2024-03-04
6:04 pm
N/A
2034-02-28
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
150,000$0150,000
(Direct)
View
2024-03-01
Option Award
2024-03-04
6:01 pm
N/A
2034-02-28
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
175,000$0175,000
(Direct)
View
2024-03-01
Option Award
2024-03-04
5:59 pm
N/A
2034-02-28
Prelude Therapeutics IncPRLDVaddi Krishna
CEO
425,000$0425,000
(Direct)
View
2024-01-04
Tax Withholding
2024-01-08
5:00 pm
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
3,844$3.77129,634
(Direct)
View
2024-01-04
Exercise
2024-01-08
5:00 pm
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
9,375$0129,634
(Direct)
View
2023-12-13
Option Award
2023-12-13
4:35 pm
N/A
N/A
Prelude Therapeutics IncPRLDBAKER BROS. ADVISORS LP
667 L.P.
BAKER JULIAN
BAKER FELIX
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
Director
10% Owner
7,936,759$3.149919,532,015
(Indirect)
View
2023-10-04
Exercise
2023-10-06
09:07 am
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
9,375$0133,478
(Direct)
View
2023-07-04
Tax Withholding
2023-07-06
4:35 pm
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
3,242$4.65133,478
(Direct)
View
2023-07-04
Exercise
2023-07-06
4:35 pm
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
9,375$0133,478
(Direct)
View
2023-06-16
Option Award
2023-06-21
4:47 pm
N/A
2033-06-15
Prelude Therapeutics IncPRLDBAKER BROS. ADVISORS LP
667 L.P.
BAKER JULIAN
BAKER FELIX
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
Director
10% Owner
47,000$047,000
(Indirect)
View
2023-06-16
Option Award
2023-06-21
4:16 pm
N/A
2033-06-15
Prelude Therapeutics IncPRLDSandor Victor
Director
23,500$023,500
(Direct)
View
2023-06-16
Option Award
2023-06-21
4:14 pm
N/A
2033-06-15
Prelude Therapeutics IncPRLDFRIEDMAN PAUL A
Director
23,500$023,500
(Direct)
View
2023-06-16
Option Award
2023-06-21
4:13 pm
N/A
2033-06-15
Prelude Therapeutics IncPRLDDier Mardi
Director
23,500$023,500
(Direct)
View
2023-06-16
Option Award
2023-06-21
4:12 pm
N/A
2033-06-15
Prelude Therapeutics IncPRLDBonita David P
Director
10% Owner
23,500$023,500
(Direct)
View
2023-06-16
Option Award
2023-06-21
4:11 pm
N/A
2033-06-15
Prelude Therapeutics IncPRLDBabler Martin
Director
23,500$023,500
(Direct)
View
2023-05-22
Option Award
2023-05-24
4:12 pm
N/A
N/A
Prelude Therapeutics IncPRLDBAKER BROS. ADVISORS LP
667 L.P.
BAKER JULIAN
BAKER FELIX
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
Director
10% Owner
1,448,222$5.7518,765,329
(Indirect)
View
2023-05-22
Option Award
2023-05-24
4:12 pm
N/A
N/A
Prelude Therapeutics IncPRLDBAKER BROS. ADVISORS LP
667 L.P.
BAKER JULIAN
BAKER FELIX
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
Director
10% Owner
11,595,256$5.749918,765,329
(Indirect)
View
2023-04-04
Exercise
2023-04-06
6:19 pm
N/A
N/A
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
37,500$0136,720
(Direct)
View
2023-03-01
Option Award
2023-03-02
4:06 pm
N/A
2033-02-28
Prelude Therapeutics IncPRLDLim Bryant David
Chief Legal Officer, Corp Sec.
250,000$0250,000
(Direct)
View
2023-02-07
Option Award
2023-02-09
4:08 pm
N/A
2033-02-06
Prelude Therapeutics IncPRLDScherle Peggy
Chief Scientific Officer
135,000$0135,000
(Direct)
View
2023-02-07
Option Award
2023-02-09
4:08 pm
N/A
2033-02-06
Prelude Therapeutics IncPRLDCombs Andrew
EVP, Head of Chemistry
135,000$0135,000
(Direct)
View
2023-02-07
Option Award
2023-02-09
4:07 pm
N/A
2033-02-06
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
135,000$0135,000
(Direct)
View
2023-02-07
Option Award
2023-02-09
4:07 pm
N/A
2033-02-06
Prelude Therapeutics IncPRLDHuang Jane
President, CMO
150,000$0150,000
(Direct)
View
Goto 0, 1, 2, 3, Next